Arvind J Trindade1, Sumant Inamdar1, Michael S Smith2, Kenneth J Chang3, Cadman L Leggett4, Charles J Lightdale5, Douglas K Pleskow6, Divyesh V Sejpal1, Guillermo J Tearney7, Rebecca M Thomas8, Michael B Wallace9. 1. Hofstra Northwell School of Medicine, Northwell Health System, Division of Gastroenterology, Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, New York, USA. 2. Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA. 3. H.H. Chao Comprehensive Digestive Disease Center, University of California, Irvine Medical Center, Orange, California, USA. 4. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. 5. Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, New York, USA. 6. Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 7. Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard-MIT Division of Health Sciences Technology, Cambridge, USA. 8. Hofstra Northwell School of Medicine, Northwell Health System, Department of Pathology, New Hyde Park, New York, USA. 9. Division of Gastroenterology, Mayo Clinic, Jacksonville, Florida, USA.
Abstract
BACKGROUND AND AIMS: Targeting neoplasia in Barrett's esophagus (BE) is challenging. Volumetric laser endomicroscopy (VLE) is a new imaging technique that allows for real time cross-sectional microstructure imaging that can detect BE neoplasia. The interobserver agreement among users in practice is unknown. METHODS: Eight high-volume users of VLE from different academic centers in the United States evaluated 120 stored VLE images blinded to the endoscopic and clinical findings. There were 30 images for each tissue type: gastric cardia, esophageal squamous mucosa, nonneoplastic BE, and neoplastic BE. Each image with BE had corresponding histology confirming the tissue diagnosis. Each normal esophagus and gastric cardia had matching endoscopic images confirming normal mucosa. These were considered the criterion standard. Respondents were asked to classify the images into 1 of each category. Agreement among the users was measured. RESULTS: The overall agreement among users was almost perfect (kappa = 0.81; 95% confidence interval [CI], 0.79-0.83). For esophageal squamous and gastric cardia, the agreement was almost perfect (kappa 0.95 and 0.86, respectively [95% CI, 0.92-0.98 and 0.83-0.89]). For nonneoplastic BE and neoplastic BE, the agreement was strong (kappa 0.66 [95% CI, 0.63-0.69] and 0.79 [95% CI, 0.75-0.82], respectively). When compared with the criterion standard, the median accuracy for identifying normal squamous mucosa, normal gastric mucosa, nonneoplastic BE, neoplastic BE, and all tissue types was 99% (95% CI, 98%-100%), 97% (95% CI, 95%-99%), 93% (95% CI, 88%-98%), 95% (95% CI, 91%-99%), and 96% (95% CI, 94%-99%), respectively. CONCLUSIONS: VLE has a high level of agreement and accuracy among high-volume users.
BACKGROUND AND AIMS: Targeting neoplasia in Barrett's esophagus (BE) is challenging. Volumetric laser endomicroscopy (VLE) is a new imaging technique that allows for real time cross-sectional microstructure imaging that can detect BE neoplasia. The interobserver agreement among users in practice is unknown. METHODS: Eight high-volume users of VLE from different academic centers in the United States evaluated 120 stored VLE images blinded to the endoscopic and clinical findings. There were 30 images for each tissue type: gastric cardia, esophageal squamous mucosa, nonneoplastic BE, and neoplastic BE. Each image with BE had corresponding histology confirming the tissue diagnosis. Each normal esophagus and gastric cardia had matching endoscopic images confirming normal mucosa. These were considered the criterion standard. Respondents were asked to classify the images into 1 of each category. Agreement among the users was measured. RESULTS: The overall agreement among users was almost perfect (kappa = 0.81; 95% confidence interval [CI], 0.79-0.83). For esophageal squamous and gastric cardia, the agreement was almost perfect (kappa 0.95 and 0.86, respectively [95% CI, 0.92-0.98 and 0.83-0.89]). For nonneoplastic BE and neoplastic BE, the agreement was strong (kappa 0.66 [95% CI, 0.63-0.69] and 0.79 [95% CI, 0.75-0.82], respectively). When compared with the criterion standard, the median accuracy for identifying normal squamous mucosa, normal gastric mucosa, nonneoplastic BE, neoplastic BE, and all tissue types was 99% (95% CI, 98%-100%), 97% (95% CI, 95%-99%), 93% (95% CI, 88%-98%), 95% (95% CI, 91%-99%), and 96% (95% CI, 94%-99%), respectively. CONCLUSIONS: VLE has a high level of agreement and accuracy among high-volume users.
Authors: Kaicheng Liang; Osman O Ahsen; Annalee Murphy; Jason Zhang; Tan H Nguyen; Benjamin Potsaid; Marisa Figueiredo; Qin Huang; Hiroshi Mashimo; James G Fujimoto Journal: BMJ Open Gastroenterol Date: 2020-09
Authors: Allon Kahn; Amrit K Kamboj; Prasuna Muppa; Tarek Sawas; Lori S Lutzke; Matthew R Buras; Michael A Golafshar; David A Katzka; Prasad G Iyer; Thomas C Smyrk; Kenneth K Wang; Cadman L Leggett Journal: Endosc Int Open Date: 2019-03-21
Authors: Kara L Raphael; Molly Stewart; Divyesh V Sejpal; Mary Cheung; Matthew J Whitson; Dennis Han; Petros C Benias; Calvin Lee; Larry S Miller; Arvind J Trindade Journal: Clin Transl Gastroenterol Date: 2019-12 Impact factor: 4.488